The Board of Directors of the Company wishes to inform that to the best of their knowledge and belief, after making due enquiry with the Company’s Directors, Major Shareholders and such other relevant persons, the Board of Directors are not aware of any of the following that may have contributed to the recent share price momentum, vis-a-vis the articles published by “The Edge” on 17 October 2022 (https://www.theedgemarkets.com/article/7eleven-silver-ridge-amtel-microlink-umw) and 24 October 2022 (https://www.theedgemarkets.com/article/us-pe-fund-carlyle-said-be-eyeing-caring-pharmacy-negotiations-advanced-stage) respectively:
- Any corporate development relating to the Group’s business and affairs that has not been previously announced that may account for the share price momentum including those in the stage of negotiation/discussion;
- Any rumour or report concerning the business and affairs of the Group that may account for the share price momentum; and
- Any other possible explanation to account for the share price momentum.
Further, the Board of Directors wishes to confirm that the Company is in compliance with Main Market Listing Requirements of Bursa Malaysia Securities Berhad (“Main LR”), in particular Paragraph 9.03 of the Main LR on immediate disclosure obligations.
This announcement is dated 1 November 2022.